Biomerica : Jumps as co says COVID-19 test with simple nasal swab available

Biomerica

11/05/2021 14:18

** Shares of diagnostic co  BMRA.O  jump 17.7% to $4.85
premarket - among top pct gainers across U.S. exchanges
    ** BMRA says its new COVID-19 antigen rapid test can now be
performed with a simple less invasive nasal swab  urn:newsml:reuters.com:*:nGNXfndZ
    ** Says swab, which takes sample from the front opening of
the nose, is less invasive and more comfortable for patients
than the deep anterior nasal swab typically used
    ** The test, which is CE marked and targeted for use outside
the United States, provides results in 15 minutes 
    ** BMRA has fallen 17.3% YTD 

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))